ANZUP 2024/25 Annual Report Now Available
Read the Report
ENZA-p PSMA-PET manuscript published in The Lancet Oncology
New findings from ANZUP's ENZA-p trial show how PSMA-PET imaging can be used for predicting response to prostate cancer therapy.
Find Out More
Another way to save lives
BCG+MM study offers alternative treatment for bladder cancer patients amid immunotherapy shortage
Read more here
ANZUP at ASCO 2025
ANZUP is proud to showcase the exciting outcomes from ANZUP’s globally significant studies across four oral presentations and four posters at the ASCO 2025 in Chicago - it's been the largest presence ANZUP has ever featured on the main stage.
Find Out More
TheraP ctDNA manuscript published in Nature Medicine
ANZUP's TheraP trial reveals how a simple blood test could transform prostate cancer treatment.
Read more here
Leave a Bequest or Legacy in your Will
Leaving a gift in your Will to ANZUP is a deeply meaningful way to support the advancement of cancer research.
Find Out More
ANZUP Strategy 2025-2028
Click Here to Read
Every meaningful advance in treatment has been the result of a clinical trial
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group mission is to improve treatments and outcomes for people affected by Below the Belt cancers.
Find out more
ANZUP x Sydney Sock Project
That’s right, we have partnered up with the Sydney Sock Project to design and produce a variety of cheeky socks. Say hello to the ‘Banana Sock’ and ‘Bum Sock’.
Grab a Pair
Donate to
improve lives!
Your Gift
Your Details
Your Payment

xx Gift of $xx

Go back
Go back

Or enter your own donation amount

0
Trials
0 +

Sites

0 +

Patients Enrolled

0

Countries

ANZUP Cancer, ANZUP

What we do

ANZUP is the leading cancer cooperative clinical trials group that brings together all of the professional disciplines and groups involved in researching and treating below the belt (penile, bladder, kidney, prostate and testicular) cancers and conduct high quality clinical research.

ANZUP identifies gaps in evidence and areas of clinical need, collaborates with the leading clinicians and researchers in below the belt cancers, and communicate frequently and effectively with the broader community along the way.
Read More
ANZUP Cancer, ANZUP

Join ANZUP

If you are not yet an ANZUP member then join our large multidisciplinary network of urogenital and prostate cancer researchers, clinicians, nurses, psychologists, scientists, allied health and consumer representatives. Membership is free.
If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.
Read More
ANZUP Cancer, ANZUP

Trials and Research

All of the major milestones in controlling cancer worldwide have come through clinical trials, but we still have a long way to go to help every person affected, at risk or diagnosed with this disease.

We have clinical trials across each cancer type, in various stages of progress: in activation, open to patient recruitment, in follow up and completed trials.
Read More

Telehealth and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.

Read More

Teleheath and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.

Read More

ANZUP Follow

The Australian and New Zealand Urogenital and Prostate cancer trials group aims to develop, foster and promote prostate and other urogenital cancer research

ANZUPtrials
Retweet on Twitter ANZUP Retweeted
oncology_bg Bishal Gyawali, MD, PhD, FASCO @oncology_bg ·
3 Aug

Just 2 weeks ago during @ANZUPtrials Annual Meeting, I had called out this phenomenon of “in mice”. My interview with @doccharris and @DrL_Krieger is now available to watch-

Reply on Twitter 1951925480585675124 Retweet on Twitter 1951925480585675124 4 Like on Twitter 1951925480585675124 10 Twitter 1951925480585675124
Retweet on Twitter ANZUP Retweeted
hagsie Prof. Haryana Dhillon @hagsie ·
3 Aug

During @ANZUPtrials #ANZUP25 I chatted with Dr Natasha Roberts about a recent paper she has had published reporting experiences of participants in #ClinicalTrials. You can listen to interview & find the paper here: https://youtu.be/6kpFhLUs5_w?si=x6YHvQRNuIjoa7Lh via @YouTube

Reply on Twitter 1951798239365316682 Retweet on Twitter 1951798239365316682 2 Like on Twitter 1951798239365316682 2 Twitter 1951798239365316682
Retweet on Twitter ANZUP Retweeted
hagsie Prof. Haryana Dhillon @hagsie ·
3 Aug

For the first time @ANZUPtrials had a session dedicated to #ClinicalTrial Coordinators, it covered running theranostics trials, #PROs, & #TeleTrials
I had a chat with session coordinator Brandan Holt via @YouTube

Reply on Twitter 1951801856575017173 Retweet on Twitter 1951801856575017173 1 Like on Twitter 1951801856575017173 Twitter 1951801856575017173
Retweet on Twitter ANZUP Retweeted
thelancetoncol The Lancet Oncology @thelancetoncol ·
1 Aug

🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00339-0/fulltext

Reply on Twitter 1951195304839024715 Retweet on Twitter 1951195304839024715 16 Like on Twitter 1951195304839024715 33 Twitter 1951195304839024715
Load More

Latest News